Page 28 - Alkermes News Today

Shares of Alkermes plc (NASDAQ:ALKS – Free Report) traded down 4.9% on Thursday . The company traded as low as $31.05 and last traded at $31.06. 1,521,398 shares were traded during mid-day trading, an increase of 16% from the average session volume of 1,314,977 shares. The stock had previously closed at $32.66. Wall Street Analyst […]

The biopharma company instead chose to re-elect its existing board members.

NEW YORK (Reuters) -Alkermes beat back activist investor Sarissa Capital Managements boardroom challenge on Thursday when shareholders re-elected all of the biotechnology companys directors in one of the years most closely watched votes.

By Svea Herbst-Bayliss NEW YORK (Reuters) - Shareholders in Alkermes have re-elected all of the biotechnology company's directors, according to two so...

NEW YORK (Reuters) -Alkermes beat back activist investor Sarissa Capital Managements boardroom challenge on Thursday when shareholders re-elected all of the biotechnology companys directors in one of the years most closely watched votes.

/PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) (the Company) today announced that, at the Companys 2023 Annual General Meeting of Shareholders (the Annual...

/PRNewswire/ -- The "Global Oncology Partnering 2016-2023: Deal Trends, Players and Financials" report has been added to ResearchAndMarkets.coms offering....

GREENWICH, Conn.--(BUSINESS WIRE)--Jun 28, 2023--

Managements Discussion and Analysis of Financial Condition and Results of Operations You should read the following discussion and analysis of our financial condition and results of operations together with our consolidated financia...

June 26 (Reuters) - Biogen shareholders elected former company executive Susan Langer as a director on Monday, weeks after her romantic partner, Alex Denner, vacated the seat and the board nominated her to replace him. ...